Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Aquaporin-1 Antibody in Neuromyelitis Optica Patients.
No evidence of human herpesvirus DNA in the CSF of multiple sclerosis patients.
Association between perceived fatigue and gait parameters measured by an instrumented treadmill in people with multiple sclerosis: a cross-sectional study.
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.
Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties.
Randomized controlled pilot study of customized pamphlets to promote physical activity and symptom self-management in women with multiple sclerosis.
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis.
Intramuscular IFNß-1a in multiple sclerosis: 'no proof of effectiveness' or 'proof of no effectiveness'?
Body mass index during adolescence, rather than childhood, is critical in determining MS risk.
Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E.
B Cells Fuel Inflammation in Multiple Sclerosis.
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception.
Effects of vigorous walking exercise on core body temperature and inhibitory control in thermosensitive persons with multiple sclerosis.
Perspectives on neuroreparative therapies for treating multiple sclerosis.
Clinical outcome measures in multiple sclerosis.
Examining vascular remodeling in the hypoxic central nervous system.
A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study.
Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.
Preface: Perspectives of an MS Researcher.
BCG vaccine for clinically isolated syndrome and MS: Infections and protective immunity.
Neurology in the developing world.
Depression during multiple sclerosis relapse: relation to disability and relapse severity.
A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms.
Progressive multifocal leukoencephalopathy in an immunocompetent patient.
Schwann cells-axon interaction in myelination.
Pages
« first
‹ previous
…
660
661
662
663
664
665
666
667
668
…
next ›
last »